Given the continued strong performance of PM stock, it seemed only logical that it will take a breather sooner or later – ...

Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

Over the past two years, Philip Morris has outperformed expectations consistently, beating EPS and revenue estimates 88% of ...

We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...